Geode Capital Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,900,074
| Closed | -$12.7M | – | 4715 |
|
|
2023
Q3 | $12.7M | Buy |
1,900,074
+174,687
| +10% | +$1.17M | ﹤0.01% | 2111 |
|
|
2023
Q2 | $15.6M | Buy |
1,725,387
+143,952
| +9% | +$1.3M | ﹤0.01% | 2022 |
|
|
2023
Q1 | $11.5M | Buy |
1,581,435
+111,175
| +8% | +$808K | ﹤0.01% | 2166 |
|
|
2022
Q4 | $10.7M | Buy |
1,470,260
+207,662
| +16% | +$1.51M | ﹤0.01% | 2224 |
|
|
2022
Q3 | $9.76M | Sell |
1,262,598
-65,945
| -5% | -$510K | ﹤0.01% | 2281 |
|
|
2022
Q2 | $9.05M | Buy |
1,328,543
+628,860
| +90% | +$4.28M | ﹤0.01% | 2325 |
|
|
2022
Q1 | $5.58M | Buy |
699,683
+78,808
| +13% | +$628K | ﹤0.01% | 2733 |
|
|
2021
Q4 | $3.48M | Buy |
620,875
+109,257
| +21% | +$612K | ﹤0.01% | 3090 |
|
|
2021
Q3 | $3.93M | Buy |
+511,618
| New | +$3.93M | ﹤0.01% | 3051 |
|